世界の創傷管理：2007〜2016年

Abstract

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents

EXECUTIVE SUMMARY

Section 1: BACKGROUND

• 1.1 Industry Structure
• 1.2 A Complex Industry
• 1.3 Major Wound Management Corporations
• 1.4 Historical Perspective and Technology Breakthroughs
• 1.5 World-Wide Regulatory and Reimbursement Environment
  • 1.5.1 Cost Effectiveness
  • 1.5.2 Clinical
  • 1.5.3 Regulatory
  • 1.5.4 Reimbursement
    • 1.5.4.1 U.S.A.
    • 1.5.4.2 European Union
    • 1.5.4.3 France
    • 1.5.4.4 Germany
    • 1.5.4.5 United Kingdom
    • 1.5.4.6 Italy
    • 1.5.4.7 Belgium
    • 1.5.4.8 Spain
    • 1.5.4.9 Scandinavia
• 1.6 Geographical Differences in Treatments of Wounds
• 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
• 1.8 Wound Management Trends
  • 1.8.1 Surgical Wounds
  • 1.8.2 Traumatic Wounds
  • 1.8.3 Burns
  • 1.8.4 Chronic Wounds
• 1.9 Market Dynamics

Section 2: CLINICAL BACKGROUND AND CASELOAD

• 2.1 Background
  • 2.1.1 A few figures
  • 2.1.2 Overview of functions
  • 2.1.3 Skin Anatomy: a summary
• 2.2 Types of Wounds
  • 2.2.1 Classification By Severity
  • 2.2.2 Classification By Morphology
  • 2.2.3 Classification By Etiology
  • 2.2.4 Color Classification
• 2.3 Surgical Wounds
• 2.4 Traumatic Wounds
• 2.5 Burns
  • 2.5.1 Debridement
  • 2.5.2 Grafting
• 2.6 Pressure Ulcers
  • 2.6.1 Ulcer classification
  • 2.6.2 Hospital-acquired ulcers
  • 2.6.3 Management of pressure ulcers
• 2.7 Venous Ulcers
• 2.8 Arterial Ulcers
• 2.9 Diabetic Ulcers
  • 2.9.1 Prevalence
  • 2.9.2 Stages of Diabetic Ulcer
  • 2.9.3 Treatment
    • 2.9.3.1 Amputations
    • 2.9.3.2 Abnormal Scarring
  • 2.9.4 Acquired Immunodeficiency Syndrome
• 2.10 Wound Healing Physiology
  • 2.10.1 Inflammatory Phase
  • 2.10.2 Proliferative Phase
    • 2.10.2.1 Angiogenesis
  • 2.10.3 Maturation Phase
• 2.11 Factors Affecting Wound Healing
  • 2.11.1 Extrinsic Factors
  • 2.11.2 Mechanical Stress
  • 2.11.3 Debris
  • 2.11.4 Temperature
  • 2.11.5 Desiccation and Maceration
  • 2.11.6 Infection
  • 2.11.7 Chemical Stress
  • 2.11.8 Medication
  • 2.11.9 Other Extrinsic Factors
  • 2.11.10 Intrinsic Factors
  • 2.11.11 Health Status
  • 2.11.12 Age Factors
  • 2.11.13 Body Build
  • 2.11.14 Nutritional Status
• 2.12 Major Treatment Categories and Regimes
• 2.13 Incidence of Treatments, Growth Rates and Trends

Section 3: PRODUCTS, TECHNOLOGIES AND MARKETS

• 3.1 Background
• 3.2 Film Dressings
  • 3.2.1 Overview
  • 3.2.2 Product Examples
  • 3.2.3 Market and Competitive Activity
• 3.3 Hydrocolloids
  • 3.3.1 Overview
  • 3.3.2 Product Examples
  • 3.3.3 Market and Competitive Activity
• 3.4 Foam Dressings
  • 3.4.1 Overview
  • 3.4.2 Product Examples
  • 3.4.3 Market and Competitive Activity
• 3.5 Alginate Dressings
  • 3.5.1 Overview
  • 3.5.2 Product Examples
  • 3.5.3 Market and Competitive Activity
• 3.6 Hydrogels
  • 3.6.1 Overview
  • 3.6.2 Product Examples
  • 3.6.3 Market and Competitive Activity
• 3.7 Non Adherent Dressings
  • 3.7.1 Overview
  • 3.7.2 Product Examples
  • 3.7.3 Market and Competitive Activity
• 3.8 Antimicrobial Dressings
  • 3.8.1 Overview
  • 3.8.2 Product Examples
  • 3.8.3 Market and Competitive Activity
• 3.9 Tissue Engineered Products
  • 3.9.1 Overview
  • 3.9.2 Traditional skin grafts
  • 3.9.3 Skin replacements
  • 3.9.4 Product Examples
  • 3.9.5 Market and Competitive Analysis
• 3.10 Pharmacological Products
  • 3.10.1 Overview
  • 3.10.2 Product Examples
    • 3.10.2.1 Growth Factors
    • 3.10.2.2 Growth factors: background
    • 3.10.2.3 Classification
    • 3.10.2.4 Regranex
    • 3.10.2.5 Other Growth Factors
    • 3.10.2.6 Non-Growth Factor Modulators
  • 3.10.3 Market and Competitive Analysis
    • 3.10.3.1 Growth Factors
    • 3.10.3.2 Non-Growth Factor Stimulants
    • 3.10.3.3 Gene Therapy
• 3.11 Physical Treatments
  • 3.11.1 Negative Pressure Devices
  • 3.11.2 Positive Pressure Devices
  • 3.11.3 Mechanically-assisted Wound Closure
  • 3.11.4 Other Physical Wound Therapies
    • 3.11.4.1 Hydrotherapy
    • 3.11.4.2 Electrical Stimulation
    • 3.11.4.3 Electromagnetic Stimulation Devices
    • 3.11.4.4 Ultraviolet Therapy
    • 3.11.4.5 Hyperbaric Oxygen Therapy
    • 3.11.4.6 Ultrasound Devices
    • 3.11.4.7 Laser Devices
    • 3.11.4.8 Wound Imaging/Documentation
  • 3.11.5 Market and Competitive Analysis
    • 3.11.5.1 Pressure Relief Devices
    • 3.11.5.2 Hydrotherapy
    • 3.11.5.3 Electrical Stimulation
    • 3.11.5.4 Hyperbaric Oxygen Therapy

Section 4: COUNTRY MARKET ANALYSIS

• 4.1 Global Overview
• 4.2 Market Estimates
  • 4.2.1 Market potential
  • 4.2.2 Leading Wound Care Companies
  • 4.2.3 Leading National Markets
• 4.3 USA
  • 4.3.1 Market Opportunity
  • 4.3.2 Market for Advanced Wound Management Products
• 4.4 Japan
  • 4.4.1 Wound Care Market
  • 4.4.2 Market Opportunity
  • 4.4.3 Leading Companies
• 4.5 Germany
  • 4.5.1 Wound Care Market
  • 4.5.2 Leading Companies
• 4.6 France
  • 4.6.1 Wound Care Market
  • 4.6.2 Leading Companies
• 4.7 Italy
  • 4.7.1 Wound Care Market
  • 4.7.2 Leading Companies
• 4.8 United Kingdom
  • 4.8.1 Wound Care Market
  • 4.8.2 Leading Companies

Section 5: COMPANY PROFILES

• 5.1 Major Companies
• 5.2 Specialist Companies
  • 5.2.1 Antimicrobial Dressings
  • 5.2.2 Oxygen Therapy
  • 5.2.3 Skin Substitutes
  • 5.2.4 Hydrogels
  • 5.2.5 Growth Factors
  • 5.2.6 Odour Control
  • 5.2.7 Other Therapeutic Modalities
  • 5.2.8 Summary Profiles